nodes	percent_of_prediction	percent_of_DWPC	metapath
Nateglinide—type 2 diabetes mellitus—polycystic ovary syndrome	0.692	1	CtDrD
Nateglinide—PPARG—polycystic ovary syndrome	0.223	1	CbGaD
Nateglinide—Gastrointestinal symptom NOS—Metformin—polycystic ovary syndrome	0.00151	0.138	CcSEcCtD
Nateglinide—CYP2C9—urine—polycystic ovary syndrome	0.00122	0.0496	CbGeAlD
Nateglinide—CYP3A4—urine—polycystic ovary syndrome	0.000933	0.0378	CbGeAlD
Nateglinide—CYP2D6—urine—polycystic ovary syndrome	0.000918	0.0372	CbGeAlD
Nateglinide—UGT1A9—endocrine gland—polycystic ovary syndrome	0.000705	0.0286	CbGeAlD
Nateglinide—Injury—Metformin—polycystic ovary syndrome	0.000701	0.0641	CcSEcCtD
Nateglinide—PPARG—embryo—polycystic ovary syndrome	0.000676	0.0274	CbGeAlD
Nateglinide—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.00066	0.0604	CcSEcCtD
Nateglinide—ABCC8—endometrium—polycystic ovary syndrome	0.000648	0.0263	CbGeAlD
Nateglinide—SLC15A1—endometrium—polycystic ovary syndrome	0.000619	0.0251	CbGeAlD
Nateglinide—SLC16A1—endometrium—polycystic ovary syndrome	0.000589	0.0239	CbGeAlD
Nateglinide—ABCC8—pituitary gland—polycystic ovary syndrome	0.000586	0.0238	CbGeAlD
Nateglinide—CYP3A7—endocrine gland—polycystic ovary syndrome	0.000586	0.0238	CbGeAlD
Nateglinide—KCNJ11—adrenal gland—polycystic ovary syndrome	0.000568	0.023	CbGeAlD
Nateglinide—Influenza—Metformin—polycystic ovary syndrome	0.000557	0.0509	CcSEcCtD
Nateglinide—SLC16A1—uterus—polycystic ovary syndrome	0.000543	0.022	CbGeAlD
Nateglinide—Sweating increased—Metformin—polycystic ovary syndrome	0.000543	0.0496	CcSEcCtD
Nateglinide—SLC16A1—pituitary gland—polycystic ovary syndrome	0.000533	0.0216	CbGeAlD
Nateglinide—SLC16A1—adipose tissue—polycystic ovary syndrome	0.000531	0.0215	CbGeAlD
Nateglinide—KCNJ11—female gonad—polycystic ovary syndrome	0.00053	0.0215	CbGeAlD
Nateglinide—ORM1—endometrium—polycystic ovary syndrome	0.000529	0.0214	CbGeAlD
Nateglinide—ABCC8—adrenal gland—polycystic ovary syndrome	0.000524	0.0212	CbGeAlD
Nateglinide—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000518	0.0473	CcSEcCtD
Nateglinide—KCNJ11—endocrine gland—polycystic ovary syndrome	0.000493	0.02	CbGeAlD
Nateglinide—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000487	0.0445	CcSEcCtD
Nateglinide—SLC16A1—adrenal gland—polycystic ovary syndrome	0.000476	0.0193	CbGeAlD
Nateglinide—Hepatobiliary disease—Metformin—polycystic ovary syndrome	0.00047	0.0429	CcSEcCtD
Nateglinide—SLC15A1—vagina—polycystic ovary syndrome	0.000464	0.0188	CbGeAlD
Nateglinide—PPARG—uterus—polycystic ovary syndrome	0.000456	0.0185	CbGeAlD
Nateglinide—ABCC8—endocrine gland—polycystic ovary syndrome	0.000454	0.0184	CbGeAlD
Nateglinide—PPARG—adipose tissue—polycystic ovary syndrome	0.000446	0.0181	CbGeAlD
Nateglinide—SLC16A1—female gonad—polycystic ovary syndrome	0.000444	0.018	CbGeAlD
Nateglinide—Oedema peripheral—Metformin—polycystic ovary syndrome	0.000439	0.0401	CcSEcCtD
Nateglinide—SLC15A1—endocrine gland—polycystic ovary syndrome	0.000434	0.0176	CbGeAlD
Nateglinide—ABCC4—uterus—polycystic ovary syndrome	0.000414	0.0168	CbGeAlD
Nateglinide—SLC16A1—endocrine gland—polycystic ovary syndrome	0.000413	0.0167	CbGeAlD
Nateglinide—ABCC4—adipose tissue—polycystic ovary syndrome	0.000405	0.0164	CbGeAlD
Nateglinide—Immune system disorder—Metformin—polycystic ovary syndrome	0.000403	0.0368	CcSEcCtD
Nateglinide—PPARG—adrenal gland—polycystic ovary syndrome	0.0004	0.0162	CbGeAlD
Nateglinide—L-Phenylalanine—TH—polycystic ovary syndrome	0.000392	0.124	CrCbGaD
Nateglinide—Malnutrition—Metformin—polycystic ovary syndrome	0.000388	0.0355	CcSEcCtD
Nateglinide—SLC15A2—endometrium—polycystic ovary syndrome	0.000387	0.0157	CbGeAlD
Nateglinide—ALB—adrenal gland—polycystic ovary syndrome	0.000375	0.0152	CbGeAlD
Nateglinide—PPARG—female gonad—polycystic ovary syndrome	0.000373	0.0151	CbGeAlD
Nateglinide—ORM1—endocrine gland—polycystic ovary syndrome	0.000371	0.015	CbGeAlD
Nateglinide—PPARG—vagina—polycystic ovary syndrome	0.00037	0.015	CbGeAlD
Nateglinide—Tremor—Metformin—polycystic ovary syndrome	0.000364	0.0332	CcSEcCtD
Nateglinide—ABCC4—adrenal gland—polycystic ovary syndrome	0.000363	0.0147	CbGeAlD
Nateglinide—Dextroamphetamine—ADRA1B—polycystic ovary syndrome	0.000354	0.112	CrCbGaD
Nateglinide—SLC15A2—pituitary gland—polycystic ovary syndrome	0.00035	0.0142	CbGeAlD
Nateglinide—PPARG—endocrine gland—polycystic ovary syndrome	0.000347	0.0141	CbGeAlD
Nateglinide—Palpitations—Metformin—polycystic ovary syndrome	0.000343	0.0313	CcSEcCtD
Nateglinide—ABCC4—female gonad—polycystic ovary syndrome	0.000338	0.0137	CbGeAlD
Nateglinide—Spirapril—ACE—polycystic ovary syndrome	0.000321	0.102	CrCbGaD
Nateglinide—ABCC4—endocrine gland—polycystic ovary syndrome	0.000315	0.0128	CbGeAlD
Nateglinide—SLC15A2—adrenal gland—polycystic ovary syndrome	0.000313	0.0127	CbGeAlD
Nateglinide—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000306	0.028	CcSEcCtD
Nateglinide—Mitiglinide—PPARG—polycystic ovary syndrome	0.000306	0.0972	CrCbGaD
Nateglinide—SLC15A2—female gonad—polycystic ovary syndrome	0.000292	0.0118	CbGeAlD
Nateglinide—SLC15A2—vagina—polycystic ovary syndrome	0.00029	0.0118	CbGeAlD
Nateglinide—Cilazapril—ACE—polycystic ovary syndrome	0.000286	0.0907	CrCbGaD
Nateglinide—Lisinopril—ACE—polycystic ovary syndrome	0.000286	0.0907	CrCbGaD
Nateglinide—Dyspepsia—Metformin—polycystic ovary syndrome	0.000279	0.0255	CcSEcCtD
Nateglinide—Ramipril—ACE—polycystic ovary syndrome	0.000277	0.0878	CrCbGaD
Nateglinide—Trandolapril—ACE—polycystic ovary syndrome	0.000277	0.0878	CrCbGaD
Nateglinide—Gastrointestinal disorder—Metformin—polycystic ovary syndrome	0.000273	0.025	CcSEcCtD
Nateglinide—Fatigue—Metformin—polycystic ovary syndrome	0.000273	0.025	CcSEcCtD
Nateglinide—SLC15A2—endocrine gland—polycystic ovary syndrome	0.000271	0.011	CbGeAlD
Nateglinide—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000265	0.0107	CbGeAlD
Nateglinide—PTGS1—endometrium—polycystic ovary syndrome	0.000264	0.0107	CbGeAlD
Nateglinide—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000259	0.0237	CcSEcCtD
Nateglinide—Urticaria—Metformin—polycystic ovary syndrome	0.000252	0.023	CcSEcCtD
Nateglinide—Abdominal pain—Metformin—polycystic ovary syndrome	0.00025	0.0229	CcSEcCtD
Nateglinide—PTGS1—uterus—polycystic ovary syndrome	0.000244	0.00988	CbGeAlD
Nateglinide—PTGS1—pituitary gland—polycystic ovary syndrome	0.000239	0.0097	CbGeAlD
Nateglinide—Dextroamphetamine—ADRA1A—polycystic ovary syndrome	0.000238	0.0756	CrCbGaD
Nateglinide—PTGS1—adipose tissue—polycystic ovary syndrome	0.000238	0.00966	CbGeAlD
Nateglinide—Asthenia—Metformin—polycystic ovary syndrome	0.000227	0.0208	CcSEcCtD
Nateglinide—Pruritus—Metformin—polycystic ovary syndrome	0.000224	0.0205	CcSEcCtD
Nateglinide—CYP3A5—female gonad—polycystic ovary syndrome	0.000222	0.00899	CbGeAlD
Nateglinide—CYP3A5—vagina—polycystic ovary syndrome	0.00022	0.00894	CbGeAlD
Nateglinide—Diarrhoea—Metformin—polycystic ovary syndrome	0.000217	0.0198	CcSEcCtD
Nateglinide—PTGS1—adrenal gland—polycystic ovary syndrome	0.000214	0.00866	CbGeAlD
Nateglinide—Enalapril—ACE—polycystic ovary syndrome	0.00021	0.0666	CrCbGaD
Nateglinide—Dizziness—Metformin—polycystic ovary syndrome	0.000209	0.0191	CcSEcCtD
Nateglinide—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000206	0.00836	CbGeAlD
Nateglinide—Bortezomib—CYP1A1—polycystic ovary syndrome	0.000205	0.0651	CrCbGaD
Nateglinide—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000203	0.00823	CbGeAlD
Nateglinide—Vomiting—Metformin—polycystic ovary syndrome	0.000201	0.0184	CcSEcCtD
Nateglinide—Rash—Metformin—polycystic ovary syndrome	0.0002	0.0183	CcSEcCtD
Nateglinide—Dermatitis—Metformin—polycystic ovary syndrome	0.0002	0.0182	CcSEcCtD
Nateglinide—PTGS1—female gonad—polycystic ovary syndrome	0.000199	0.00808	CbGeAlD
Nateglinide—PTGS1—vagina—polycystic ovary syndrome	0.000198	0.00803	CbGeAlD
Nateglinide—Nausea—Metformin—polycystic ovary syndrome	0.000188	0.0172	CcSEcCtD
Nateglinide—PTGS1—endocrine gland—polycystic ovary syndrome	0.000185	0.00751	CbGeAlD
Nateglinide—CYP2D6—female gonad—polycystic ovary syndrome	0.000164	0.00664	CbGeAlD
Nateglinide—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000155	0.00627	CbGeAlD
Nateglinide—CYP2D6—endocrine gland—polycystic ovary syndrome	0.000152	0.00617	CbGeAlD
Nateglinide—CYP3A7—Metabolism—AKR1C1—polycystic ovary syndrome	1.06e-05	0.000228	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.06e-05	0.000228	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—GNAS—polycystic ovary syndrome	1.05e-05	0.000226	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—STAR—polycystic ovary syndrome	1.04e-05	0.000225	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—NCOR1—polycystic ovary syndrome	1.04e-05	0.000225	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	1.04e-05	0.000225	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NAMPT—polycystic ovary syndrome	1.04e-05	0.000224	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	1.04e-05	0.000224	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.03e-05	0.000223	CbGpPWpGaD
Nateglinide—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	1.03e-05	0.000223	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKR1C1—polycystic ovary syndrome	1.03e-05	0.000221	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP11A1—polycystic ovary syndrome	1.03e-05	0.000221	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.02e-05	0.00022	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—NCOR1—polycystic ovary syndrome	1.01e-05	0.000218	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.01e-05	0.000217	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—NCOR1—polycystic ovary syndrome	9.97e-06	0.000215	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	9.94e-06	0.000214	CbGpPWpGaD
Nateglinide—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	9.93e-06	0.000214	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—CYP1A1—polycystic ovary syndrome	9.89e-06	0.000213	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	9.88e-06	0.000213	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	9.82e-06	0.000212	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C2—polycystic ovary syndrome	9.79e-06	0.000211	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TEAD2—polycystic ovary syndrome	9.79e-06	0.000211	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SULT2A1—polycystic ovary syndrome	9.75e-06	0.00021	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C2—polycystic ovary syndrome	9.71e-06	0.000209	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TEAD2—polycystic ovary syndrome	9.71e-06	0.000209	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—AKR1C3—polycystic ovary syndrome	9.7e-06	0.000209	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NCOR1—polycystic ovary syndrome	9.62e-06	0.000207	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—TH—polycystic ovary syndrome	9.62e-06	0.000207	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—CYP1A1—polycystic ovary syndrome	9.59e-06	0.000207	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP17A1—polycystic ovary syndrome	9.55e-06	0.000206	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SULT2A1—polycystic ovary syndrome	9.45e-06	0.000204	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—CYP1A1—polycystic ovary syndrome	9.45e-06	0.000204	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—RRM2—polycystic ovary syndrome	9.45e-06	0.000204	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	9.42e-06	0.000203	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—SLC2A4—polycystic ovary syndrome	9.35e-06	0.000202	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	9.34e-06	0.000201	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HMMR—polycystic ovary syndrome	9.3e-06	0.0002	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—MTHFR—polycystic ovary syndrome	9.22e-06	0.000199	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	9.19e-06	0.000198	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—RRM2—polycystic ovary syndrome	9.16e-06	0.000197	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—YAP1—polycystic ovary syndrome	9.11e-06	0.000196	CbGpPWpGaD
Nateglinide—ALB—Metabolism—STAR—polycystic ovary syndrome	8.99e-06	0.000194	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	8.99e-06	0.000194	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—MTHFR—polycystic ovary syndrome	8.94e-06	0.000193	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—NR3C1—polycystic ovary syndrome	8.9e-06	0.000192	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	8.88e-06	0.000191	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HSD3B1—polycystic ovary syndrome	8.87e-06	0.000191	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	8.86e-06	0.000191	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—YAP1—polycystic ovary syndrome	8.83e-06	0.00019	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—MTHFR—polycystic ovary syndrome	8.81e-06	0.00019	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP19A1—polycystic ovary syndrome	8.79e-06	0.00019	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NAMPT—polycystic ovary syndrome	8.75e-06	0.000189	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—GNAS—polycystic ovary syndrome	8.71e-06	0.000188	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP11A1—polycystic ovary syndrome	8.64e-06	0.000186	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NAMPT—polycystic ovary syndrome	8.48e-06	0.000183	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.43e-06	0.000182	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP11A1—polycystic ovary syndrome	8.37e-06	0.00018	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—VEGFA—polycystic ovary syndrome	8.35e-06	0.00018	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.31e-06	0.000179	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—TH—polycystic ovary syndrome	8.26e-06	0.000178	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PNPLA2—polycystic ovary syndrome	8.21e-06	0.000177	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—AKR1C3—polycystic ovary syndrome	8.16e-06	0.000176	CbGpPWpGaD
Nateglinide—ABCC4—Hemostasis—VEGFA—polycystic ovary syndrome	8.14e-06	0.000176	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PNPLA2—polycystic ovary syndrome	8.14e-06	0.000175	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	8.1e-06	0.000175	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	8.1e-06	0.000175	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—LHB—polycystic ovary syndrome	8.09e-06	0.000174	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—SLC2A4—polycystic ovary syndrome	8.04e-06	0.000173	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP17A1—polycystic ovary syndrome	8.03e-06	0.000173	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HMMR—polycystic ovary syndrome	8.01e-06	0.000173	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—HSD3B2—polycystic ovary syndrome	7.91e-06	0.00017	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—AKR1C3—polycystic ovary syndrome	7.91e-06	0.00017	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—GNAS—polycystic ovary syndrome	7.85e-06	0.000169	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP17A1—polycystic ovary syndrome	7.79e-06	0.000168	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SRD5A1—polycystic ovary syndrome	7.78e-06	0.000168	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SRD5A1—polycystic ovary syndrome	7.71e-06	0.000166	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	7.66e-06	0.000165	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	7.64e-06	0.000165	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP19A1—polycystic ovary syndrome	7.56e-06	0.000163	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.55e-06	0.000163	CbGpPWpGaD
Nateglinide—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.54e-06	0.000163	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	7.53e-06	0.000162	CbGpPWpGaD
Nateglinide—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.51e-06	0.000162	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—NCOR1—polycystic ovary syndrome	7.48e-06	0.000161	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—PPARG—polycystic ovary syndrome	7.48e-06	0.000161	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—STAR—polycystic ovary syndrome	7.42e-06	0.00016	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—POMC—polycystic ovary syndrome	7.38e-06	0.000159	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.36e-06	0.000159	CbGpPWpGaD
Nateglinide—ABCC8—Metabolism—INS—polycystic ovary syndrome	7.33e-06	0.000158	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.27e-06	0.000157	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—PPARG—polycystic ovary syndrome	7.25e-06	0.000156	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	7.16e-06	0.000154	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—POMC—polycystic ovary syndrome	7.15e-06	0.000154	CbGpPWpGaD
Nateglinide—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	7.15e-06	0.000154	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—PPARG—polycystic ovary syndrome	7.15e-06	0.000154	CbGpPWpGaD
Nateglinide—KCNJ11—Metabolism—INS—polycystic ovary syndrome	7.11e-06	0.000153	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—CYP1A1—polycystic ovary syndrome	7.09e-06	0.000153	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	7.05e-06	0.000152	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—POMC—polycystic ovary syndrome	7.05e-06	0.000152	CbGpPWpGaD
Nateglinide—SLC16A1—Metabolism—INS—polycystic ovary syndrome	7.01e-06	0.000151	CbGpPWpGaD
Nateglinide—ALB—Metabolism—LHB—polycystic ovary syndrome	6.97e-06	0.00015	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—TH—polycystic ovary syndrome	6.95e-06	0.00015	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	6.83e-06	0.000147	CbGpPWpGaD
Nateglinide—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	6.81e-06	0.000147	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—SLC2A4—polycystic ovary syndrome	6.76e-06	0.000146	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—GNAS—polycystic ovary syndrome	6.75e-06	0.000145	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—TH—polycystic ovary syndrome	6.74e-06	0.000145	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HMMR—polycystic ovary syndrome	6.61e-06	0.000143	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—MTHFR—polycystic ovary syndrome	6.61e-06	0.000142	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	6.6e-06	0.000142	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	6.58e-06	0.000142	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.56e-06	0.000141	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—SLC2A4—polycystic ovary syndrome	6.55e-06	0.000141	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—NCOR1—polycystic ovary syndrome	6.43e-06	0.000138	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.4e-06	0.000138	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.4e-06	0.000138	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP19A1—polycystic ovary syndrome	6.36e-06	0.000137	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	6.32e-06	0.000136	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HSD3B1—polycystic ovary syndrome	6.31e-06	0.000136	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.26e-06	0.000135	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	6.24e-06	0.000135	CbGpPWpGaD
Nateglinide—PPARG—Gene Expression—SERPINE1—polycystic ovary syndrome	6.21e-06	0.000134	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.18e-06	0.000133	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP19A1—polycystic ovary syndrome	6.16e-06	0.000133	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—CYP1A1—polycystic ovary syndrome	6.09e-06	0.000131	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	6.07e-06	0.000131	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	5.9e-06	0.000127	CbGpPWpGaD
Nateglinide—ALB—Metabolism—RRM2—polycystic ovary syndrome	5.88e-06	0.000127	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.86e-06	0.000126	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.81e-06	0.000125	CbGpPWpGaD
Nateglinide—PPARG—Developmental Biology—IL6—polycystic ovary syndrome	5.77e-06	0.000124	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—LHB—polycystic ovary syndrome	5.75e-06	0.000124	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.7e-06	0.000123	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—MTHFR—polycystic ovary syndrome	5.68e-06	0.000122	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—GNAS—polycystic ovary syndrome	5.67e-06	0.000122	CbGpPWpGaD
Nateglinide—ALB—Metabolism—YAP1—polycystic ovary syndrome	5.67e-06	0.000122	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—IGF1—polycystic ovary syndrome	5.64e-06	0.000122	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—AKT2—polycystic ovary syndrome	5.64e-06	0.000121	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—HSD3B2—polycystic ovary syndrome	5.62e-06	0.000121	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.58e-06	0.00012	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—GNAS—polycystic ovary syndrome	5.5e-06	0.000119	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C1—polycystic ovary syndrome	5.45e-06	0.000117	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NAMPT—polycystic ovary syndrome	5.45e-06	0.000117	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.41e-06	0.000117	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—NCOR1—polycystic ovary syndrome	5.4e-06	0.000116	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.4e-06	0.000116	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	5.38e-06	0.000116	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.37e-06	0.000116	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	5.36e-06	0.000115	CbGpPWpGaD
Nateglinide—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.34e-06	0.000115	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—POMC—polycystic ovary syndrome	5.29e-06	0.000114	CbGpPWpGaD
Nateglinide—PPARG—Metabolism—INS—polycystic ovary syndrome	5.26e-06	0.000113	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—NCOR1—polycystic ovary syndrome	5.24e-06	0.000113	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—CYP1A1—polycystic ovary syndrome	5.12e-06	0.00011	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	5.09e-06	0.00011	CbGpPWpGaD
Nateglinide—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	5.08e-06	0.000109	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—TH—polycystic ovary syndrome	5.02e-06	0.000108	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SULT2A1—polycystic ovary syndrome	5.01e-06	0.000108	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	5e-06	0.000108	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.97e-06	0.000107	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—CYP1A1—polycystic ovary syndrome	4.97e-06	0.000107	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.89e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—RRM2—polycystic ovary syndrome	4.86e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.85e-06	0.000105	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.81e-06	0.000104	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—MTHFR—polycystic ovary syndrome	4.78e-06	0.000103	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—YAP1—polycystic ovary syndrome	4.68e-06	0.000101	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.64e-06	0.0001	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—MTHFR—polycystic ovary syndrome	4.63e-06	9.98e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—PPARG—polycystic ovary syndrome	4.61e-06	9.92e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.59e-06	9.9e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—POMC—polycystic ovary syndrome	4.54e-06	9.79e-05	CbGpPWpGaD
Nateglinide—UGT1A9—Metabolism—INS—polycystic ovary syndrome	4.52e-06	9.73e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NAMPT—polycystic ovary syndrome	4.5e-06	9.69e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.46e-06	9.61e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP11A1—polycystic ovary syndrome	4.44e-06	9.57e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.43e-06	9.55e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.4e-06	9.49e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.37e-06	9.42e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—TH—polycystic ovary syndrome	4.33e-06	9.32e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.32e-06	9.32e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	4.21e-06	9.07e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—AKR1C3—polycystic ovary syndrome	4.19e-06	9.04e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.16e-06	8.96e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP17A1—polycystic ovary syndrome	4.13e-06	8.9e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	4.13e-06	8.89e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	4.1e-06	8.84e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	4.09e-06	8.82e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	3.96e-06	8.53e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.91e-06	8.42e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—PPARG—polycystic ovary syndrome	3.87e-06	8.35e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—POMC—polycystic ovary syndrome	3.82e-06	8.23e-05	CbGpPWpGaD
Nateglinide—CYP3A7—Metabolism—INS—polycystic ovary syndrome	3.8e-06	8.19e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.76e-06	8.11e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—PPARG—polycystic ovary syndrome	3.75e-06	8.09e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.7e-06	7.98e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—POMC—polycystic ovary syndrome	3.7e-06	7.98e-05	CbGpPWpGaD
Nateglinide—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.69e-06	7.94e-05	CbGpPWpGaD
Nateglinide—PTGS1—Metabolism—INS—polycystic ovary syndrome	3.68e-06	7.94e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.68e-06	7.93e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—TH—polycystic ovary syndrome	3.57e-06	7.7e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.56e-06	7.68e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.54e-06	7.63e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.53e-06	7.61e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—SLC2A4—polycystic ovary syndrome	3.47e-06	7.49e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.45e-06	7.44e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.44e-06	7.42e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—NCOR1—polycystic ovary syndrome	3.36e-06	7.25e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.28e-06	7.06e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP19A1—polycystic ovary syndrome	3.27e-06	7.04e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.24e-06	6.98e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.19e-06	6.87e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.17e-06	6.84e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	3.06e-06	6.59e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.97e-06	6.41e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.94e-06	6.34e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—GNAS—polycystic ovary syndrome	2.92e-06	6.28e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.9e-06	6.26e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.89e-06	6.23e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.8e-06	6.03e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—NCOR1—polycystic ovary syndrome	2.78e-06	5.99e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.76e-06	5.95e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.75e-06	5.93e-05	CbGpPWpGaD
Nateglinide—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.75e-06	5.92e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.74e-06	5.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.7e-06	5.82e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—CYP1A1—polycystic ovary syndrome	2.63e-06	5.68e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.61e-06	5.63e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—MTHFR—polycystic ovary syndrome	2.46e-06	5.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.43e-06	5.25e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.41e-06	5.2e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—POMC—polycystic ovary syndrome	2.38e-06	5.12e-05	CbGpPWpGaD
Nateglinide—ALB—Metabolism—INS—polycystic ovary syndrome	2.36e-06	5.1e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.34e-06	5.03e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.27e-06	4.9e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.14e-06	4.6e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—PPARG—polycystic ovary syndrome	1.99e-06	4.29e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.97e-06	4.25e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—POMC—polycystic ovary syndrome	1.96e-06	4.23e-05	CbGpPWpGaD
Nateglinide—CYP2D6—Metabolism—INS—polycystic ovary syndrome	1.95e-06	4.21e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.95e-06	4.19e-05	CbGpPWpGaD
Nateglinide—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.94e-06	4.17e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.91e-06	4.11e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.82e-06	3.91e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.72e-06	3.71e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.61e-06	3.46e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.3e-06	2.81e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.28e-06	2.77e-05	CbGpPWpGaD
Nateglinide—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.28e-06	2.75e-05	CbGpPWpGaD
